Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Watts

Showing results (131-140 of 183) with videos related to

Pageof 19
Sort By:
BMJ Open|September 30, 2022
Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra studyAmeeta Retzer, Stephanie Sivell, Hannah Scott, et al.
Neuro-Oncology Practice|September 21, 2022
Reconfiguration from emergency to urgent elective neurosurgery for glioblastoma patients improves length of stay, surgical adjunct use, and extent of resective surgeryRosa Sun, Shivam Sharma, Helen Benghiat, et al.
Neuro-Oncology|September 11, 2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningiomaJulia Furtner, Veronika Schöpf, Katharina Seystahl, et al.
Neuro-Oncology Advances|September 18, 2023
Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods studyAmeeta Retzer, Elin Baddeley, Stephanie Sivell, et al.
Journal of Neuro-Oncology|November 16, 2017
Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefitWilliam Sage, Mathew Guilfoyle, Catriona Luney, et al.
Health Technology Assessment (Winchester, England)|March 9, 2026
Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCTMichael D Jenkinson, Helen Bulbeck, Jade Carruthers, et al.
Neuro-Oncology Advances|July 10, 2020
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trialLucy Brazil, Angela L Swampillai, Ka Man Mak, et al.
Neuro-Oncology Practice|May 11, 2026
Seizure prophylaxis in glioma surgery (SPRING): A multi-center, unblinded, randomized trialMichael D Jenkinson, Helen Bulbeck, Jackie Burns, et al.
Cancer Research|November 20, 2014
Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zoneSara Gm Piccirillo, Inmaculada Spiteri, Andrea Sottoriva, et al.
Neuro-Oncology|April 30, 2020
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trialCatherine Hanna, Kathreena M Kurian, Karin Williams, et al.
Pageof 19

Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
BMJ Open|September 30, 2022
Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra studyAmeeta Retzer, Stephanie Sivell, Hannah Scott, et al.
Neuro-Oncology Practice|September 21, 2022
Reconfiguration from emergency to urgent elective neurosurgery for glioblastoma patients improves length of stay, surgical adjunct use, and extent of resective surgeryRosa Sun, Shivam Sharma, Helen Benghiat, et al.
Neuro-Oncology|September 11, 2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningiomaJulia Furtner, Veronika Schöpf, Katharina Seystahl, et al.
Neuro-Oncology Advances|September 18, 2023
Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods studyAmeeta Retzer, Elin Baddeley, Stephanie Sivell, et al.
Journal of Neuro-Oncology|November 16, 2017
Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefitWilliam Sage, Mathew Guilfoyle, Catriona Luney, et al.
Health Technology Assessment (Winchester, England)|March 9, 2026
Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCTMichael D Jenkinson, Helen Bulbeck, Jade Carruthers, et al.
Neuro-Oncology Advances|July 10, 2020
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trialLucy Brazil, Angela L Swampillai, Ka Man Mak, et al.
Neuro-Oncology Practice|May 11, 2026
Seizure prophylaxis in glioma surgery (SPRING): A multi-center, unblinded, randomized trialMichael D Jenkinson, Helen Bulbeck, Jackie Burns, et al.
Cancer Research|November 20, 2014
Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zoneSara Gm Piccirillo, Inmaculada Spiteri, Andrea Sottoriva, et al.
Neuro-Oncology|April 30, 2020
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trialCatherine Hanna, Kathreena M Kurian, Karin Williams, et al.
Pageof 19